Free Trial
CVE:DM

Datametrex AI (DM) Stock Price, News & Analysis

Datametrex AI logo
C$0.12 -0.01 (-3.85%)
As of 10:50 AM Eastern

About Datametrex AI Stock (CVE:DM)

Key Stats

Today's Range
C$0.12
C$0.13
50-Day Range
C$0.01
C$0.13
52-Week Range
C$0.10
C$1.35
Volume
20,568 shs
Average Volume
42,130 shs
Market Capitalization
C$75.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products. The company provides big data, artificial intelligence, and system integration services, as well as sells hardware equipment. In addition, the company offers AnalyticsGPT, an AI and Machine Learning platform; cyber security nexology comprising NexaSecurity, a social media discovery and monitoring platform and NexaSMART; imagine health care centers, a multidisciplinary healthcare facility; Medi-call, a telehealth platform for iOS and Android devices, as well as mobile gaming, a cereal crunch app. Further, it provides mobile charging services, EV charging stations, Mobile EV chargers, and AC EV chargers. The company is headquartered in Toronto, Canada.

Receive DM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Datametrex AI and its competitors with MarketBeat's FREE daily newsletter.

DM Stock News Headlines

Datametrex Announces Effective Date for Share Consolidation
DataMetrex AI Ltd.: Datametrex Announces Share Consolidation
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.
Datametrex Announces Share Consolidation
DataMetrex AI Ltd.: DataMetrex Receives New P.O. for $440k
See More Headlines

DM Stock Analysis - Frequently Asked Questions

Datametrex AI's stock was trading at C$0.01 at the beginning of 2025. Since then, DM shares have increased by 2,500.0% and is now trading at C$0.13.
View the best growth stocks for 2025 here
.

Shares of DM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Datametrex AI investors own include InPlay Oil (IPO), Bank of Nova Scotia (BNS), Curaleaf (CURLF), CloudMD Software & Services (DOC), Canadian Imperial Bank of Commerce (CM), Enbridge (ENB) and Bionano Genomics (BNGO).

Industry, Sector and Symbol

Industry
Information Technology Services
Sub-Industry
Machinery
CIK
N/A
Fax
N/A
Employees
1,370
Year Founded
N/A

Profitability

Net Income
C$-17,370,000.00
Net Margins
-211.50%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$8.21 million
Cash Flow
C$0.05 per share

Miscellaneous

Free Float
N/A
Market Cap
C$78.52 million
Optionable
Not Optionable
Beta
2.59
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:DM) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners